NASDAQ:GANX

Gain Therapeutics, Inc.

Stock

USD

Last Close

1.07

30/08 20:00

Market Cap

21.66M

Beta: 0.35

Volume Today

555.18K

Avg: 82.23K

PE Ratio

−2.52

PFCF: −5.26

Overview Analysis Financials Filings people Ownership API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-1.11M -	-2.19M 98.40%	-3.58M 63.11%	-13.89M 288.26%	-17.59M 26.64%	-22.27M 26.59%
depreciation and amortization	741 -	2.57K 246.96%	9.59K 273.08%	15.48K 61.43%	64.17K 314.41%	83.58K 30.25%
deferred income tax				1.09M -		643.16K -
stock based compensation			81.64K -	839.37K 928.14%	1.53M 81.85%	3.26M 113.51%
change in working capital	319.23K -	312.26K 2.18%	237.50K 23.94%	-385.11K 262.15%	1.51M 493.36%	-643.16K 142.46%
accounts receivables		-8.35K -	-196 97.65%	8.26K 4,316.33%
inventory		96.52K -	-28.53K 129.56%	93.32K 427.11%
accounts payables	117.69K -	5.11K 95.66%	395.54K 7,643.60%	-521.39K 231.82%	1.07M 304.59%	-643.16K 160.29%
other working capital	201.55K -	218.99K 8.65%	-129.31K 159.05%	34.70K 126.83%	448.15K 1,191.46%	643.16K 43.52%
other non cash items	41.05K -	10.10K 75.39%	8.71K 13.81%	-34.13K 491.95%	-206.86K 506.01%	59.04K 128.54%
net cash provided by operating activities	-744.51K -	-1.87M 150.97%	-3.24M 73.41%	-12.37M 281.63%	-14.69M 18.81%	-18.87M 28.41%
investments in property plant and equipment	-7.99K -	-13.72K 71.82%	-20.83K 51.76%	-94.21K 352.38%	-118.95K 26.26%	-15.36K 87.09%
acquisitions net					14.66M -
purchases of investments					-17.74M -	-1.96M 88.97%
sales maturities of investments					3.08M -	12.19M 295.99%
other investing activites	7.99K -				-14.66M -
net cash used for investing activites	-7.99K -	-13.72K 71.82%	-20.83K 51.76%	-94.21K 352.38%	-14.77M 15,582.52%	10.22M 169.19%
debt repayment			-738.28K -	-21.95K 97.03%	-78.77K 258.86%
common stock issued		1.75M -	177 99.99%	42.63M 24,084,644.63%
common stock repurchased
dividends paid
other financing activites	983.78K -	1.75M 78.04%	11.23M 540.89%	-841.27K 107.49%		12.64M -
net cash used provided by financing activities	983.78K -	1.75M 78.04%	10.49M 498.75%	41.77M 298.27%	-78.77K 100.19%	12.64M 16,147.61%
effect of forex changes on cash	6.61K -	33.56K 408.01%	-35.32K 205.22%	100.78K 385.35%	-23.80K 123.61%	488.40K 2,152.38%
net change in cash	237.88K -	-97.19K 140.86%	7.19M 7,498.55%	29.41M 308.97%	-29.57M 200.55%	4.49M 115.17%
cash at beginning of period	173.00K -	410.89K 137.50%	313.70K 23.65%	7.50M 2,292.18%	36.91M 391.88%	7.34M 80.11%
cash at end of period	410.89K -	313.70K 23.65%	7.50M 2,292.18%	36.91M 391.88%	7.34M 80.11%	11.83M 61.10%
operating cash flow	-744.51K -	-1.87M 150.97%	-3.24M 73.41%	-12.37M 281.63%	-14.69M 18.81%	-18.87M 28.41%
capital expenditure	-7.99K -	-13.72K 71.82%	-20.83K 51.76%	-94.21K 352.38%	-118.95K 26.26%	-15.36K 87.09%
free cash flow	-752.50K -	-1.88M 150.13%	-3.26M 73.26%	-12.46M 282.08%	-14.81M 18.87%	-18.88M 27.48%

All numbers in USD (except ratios and percentages)